A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results
A new biweekly GLP-1 drug called bofanglutide showed strong blood sugar and weight loss results in a Phase 2b trial. Monthly injectables and oral pills are also in the pipeline.
Read the full article1d agoen
You might also wanna read
Former NY Nurse Hit with Record $544,000 Penalty for Faking Children's Vaccination Records
Medical Daily·1h ago
Contaminated Eye Drops? Recent Recalls Raise New Questions About How Sterility Failures Can Threaten Vision
Medical Daily·3h ago
The Illness Kaylee McKeown Mistook for the Flu Has Forced the Olympic Champion Out of Competition
Medical Daily·4h ago
Can A 'Mental Health Glow Up' Improve Cancer Care? Katie Thurston's Update Sparks A Bigger Conversation
Medical Daily·5h ago
Dimora Sacrum Silicone Absorbent Soft Dressing Review: Comfortable, Highly Absorbent Protection for Pressure Sores
Medical Daily·7h ago
Millennials and Gen Z Are Aging Faster Than Previous Generations, and Scientists Say It May Fuel Rising Cancer Rates
Medical Daily·10h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.